Related Experiment Video
Updated: Feb 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease
Elisa A Colombo1, Nursel H Elcioglu2,3, Claudio Graziano4
1Dipartimento di Scienze della Salute, Università degli Studi di Milano, via Antonio di Rudinì 8, 20142, Milan, Italy. elisaadele.colombo@unimi.it.
Purpose:
Poikiloderma with neutropenia (PN) is a genodermatosis currently described in 77 patients, all presenting with early-onset poikiloderma, neutropenia, and several additional signs. Biallelic loss-of-function mutations in USB1 gene are detected in all molecularly tested patients but genotype-phenotype correlation remains elusive. Cancer predisposition is recognized among PN features and pathogenic variants found in patients who developed early in life myelodysplasia (n = 12), acute myeloid leukemia (n = 2), and squamous cell carcinoma (n = 2) should be kept into account in management and follow-up of novel patients. This will hopefully allow achieving data clustered on specific mutations relevant to oncological surveillance of the carrier patients.
Methods:
We describe the clinical features of three unreported PN patients and characterize their USB1 pathogenic variants by transcript analysis to get insights into the effect on the overall phenotype and disease evolution.
Results:
A Turkish boy is homozygous for the c.531delA deletion, a recurrent mutation in Turkey; an adult Italian male is compound heterozygous for two nonsense mutations, c.243G>A and c.541C>T, while an Italian boy is homozygous for the splicing c.683_693+1del variant. The identified mutations have already been reported in PN patients who developed hematologic or skin cancer. Aberrant mRNAs of all four mutated alleles could be identified confirming that transcripts of USB1 main isoform either carrying stop codons or mis-spliced may at least partially escape nonsense-mediated decay.
Conclusions:
Our study addresses the need of gathering insights on genotype-phenotype correlations in newly described PN patients, by transcript analysis and information on disease evolution of reported patients with the same pathogenic variants.
Insights
Poikiloderma with neutropenia (PN) is a rare genetic disorder. This study analyzes USB1 gene mutations, revealing insights into genotype-phenotype correlations and cancer risks in affected individuals.
Area of Science:
- Genetics
- Dermatology
- Oncology
Background:
- Poikiloderma with neutropenia (PN) is a rare genodermatosis characterized by early-onset poikiloderma and neutropenia.
- Biallelic loss-of-function mutations in the USB1 gene are the known cause of PN, but genotype-phenotype correlations are not well understood.
- Cancer predisposition is a recognized feature of PN, necessitating careful monitoring for hematologic and skin cancers.
Observation:
- Three new PN patients with distinct USB1 mutations were analyzed.
- Transcript analysis revealed aberrant messenger RNA (mRNA) products from mutated USB1 alleles.
- Identified mutations were previously associated with cancer development in PN patients.
Findings:
- Genotype-phenotype correlations in PN were investigated through transcript analysis of novel USB1 variants.
- Aberrant mRNA transcripts, including those with stop codons or mis-splicing, were detected and may partially escape nonsense-mediated decay.
- The study identified specific USB1 mutations linked to cancer development in PN patients.
Implications:
- Understanding genotype-phenotype correlations in PN is crucial for managing patients.
- Transcript analysis provides insights into the molecular mechanisms underlying PN.
- Identifying specific mutations associated with cancer risk can guide oncological surveillance strategies for PN patients.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
04:01Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Related Concept Videos
The Evidence for Evolution
Viral Mutations
Patient-centered Care
Mutations
Convergent Evolution
Data Reporting and Recording